Stay updated on Pembrolizumab + Nab-Paclitaxel in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab + Nab-Paclitaxel in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab + Nab-Paclitaxel in NSCLC Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Added related topics links for Lung cancer and MedlinePlus Genetics to the page; these expand available health-information resources without altering study details.
    Difference
    0.2%
    Check dated 2026-06-19T22:43:58.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The recruitment status is updated to closed, and new guidance links were added to help users read the study record and join a study. Minor UI/content updates include a header label adjustment (Intervention/Treatment), a revision tag, and removal of some related-topic terms.
    Difference
    0.6%
    Check dated 2026-06-12T16:00:45.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.5.4 to v3.5.5, indicating a minor metadata update. No study data or visible content appears to be affected.
    Difference
    0.1%
    Check dated 2026-06-05T11:59:33.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The related topics header and its entries (Lung cancer and MedlinePlus Genetics) were removed, reducing quick links to disease-related resources on the page.
    Difference
    0.2%
    Check dated 2026-05-29T08:40:11.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The page shows a revision update from v3.5.3 to v3.5.4, signaling a deployment/build update. No study content or parameters appear to be modified.
    Difference
    0.1%
    Check dated 2026-05-15T02:17:18.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    Revision: v3.5.3 has replaced Revision: v3.5.2 as the page version label, indicating a new site release; no study information or visible content appears to be affected.
    Difference
    0.1%
    Check dated 2026-04-30T17:22:13.000Z thumbnail image

Stay in the know with updates to Pembrolizumab + Nab-Paclitaxel in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Nab-Paclitaxel in NSCLC Clinical Trial page.